Skip to content

Office of Fellowship Training (OFT)

OFT Mission

The mission of the Office of Fellowship Training is:

  • To support and promote a productive and fulfilling research training experience in the NIMH Intramural Research Program
  • To encourage career planning and guide career management through trainee use of Individual Development Plans (IDPs)
  • To provide programs and services to assist trainees in discovering and clarifying career choices
  • To provide opportunities and to encourage trainees to build a professional skill set which enables them to become world leaders in academic and non-academic careers

Trainee Successes: Past & Present

Mark J. Niciu, M.D., Ph.D.

Mark J. Niciu, M.D., Ph.D.

Mark J. Niciu, M.D., Ph.D., joined the Experimental Therapeutics and Pathophysiology Branch of the NIMH in July 2012, under the supervision of Carlos A. Zarate Jr. M.D. as a clinical fellow. He completed his adult psychiatry residency in the Neuroscience Research Training Program (NRTP) at Yale University and, during his 4th year, was the program-wide chief resident and chief resident on the Clinical Neuroscience Research Unit. Mark is the lead associate investigator on the following research protocol: “The Neurophysiological Effects of Intravenous Alcohol as Potential Biomarkers of Ketamine’s Rapid Antidepressant Effects in Major Depressive Disorder” ( identifier: NCT02122562). This protocol served as the research plan for Dr. Niciu’s K99R00 “Pathway to Independence” career development award application, which he received and commenced in January 2016. Dr. Niciu has also received a Brain and Behavior Research Foundation/NARSAD Young Investigator award for his collaborative stem cell work with the Laboratory of Neurogenetics in the National Institute of Alcoholism and Alcohol Abuse (NIAAA).


Fellowship – Experimental Therapeutics and Pathophysiology Branch (ETPB), NIMH, Bethesda, MD

Residency – Yale University Department of Psychiatry, Neuroscience Research Training Program, New Haven, CT

Medical/Graduate Schools (Medical Scientist Training Program) – University of Connecticut School of Medicine, Farmington, CT

College – Manhattan College, Riverdale, NY

NIMH publications (3 Representatives Selected)

  1. Niciu MJ, Luckenbaugh DA, Ionescu DF, Richards EM, Vande Voort JL, Ballard ED, Brutsche NE, Furey ML, Zarate CA Jr (2014) Ketamine’s antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder. Int J Neuropsychopharmacol 18(1); 
  2. Niciu MJ, Luckenbaugh DA, Ionescu DF, Guevara S, Machado-Vieira R, Richards EM, Brutsche NE, Nolan NM, Zarate CA Jr (2014) Clinical predictors of ketamine response in treatment-resistant major depression. J Clin Psychiatry75(5):e417-23; 
  3. Niciu MJ, Henter ID, Luckenbaugh DA, Zarate CA Jr, Charney DS (2014) Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds. Annu Rev Pharmacol Toxicol 54:119-39;